Soft Tissue Evaluation Around Implants Using Prf or a Palatal Pedicle
Clinical Evaluation of Peri-Implant Soft Tissue Around Immediately Placed Implants Using PRF Membrane Versus The Palatal Pedicle Soft Tissue Graft: A Randomized Controlled Clinical Trial.
1 other identifier
interventional
18
0 countries
N/A
Brief Summary
Clinical Evaluation of Peri-Implant Soft Tissue Around Immediately Placed Implants Using PRF Membrane Versus The Palatal Pedicle Soft Tissue Graft: A Randomized Controlled Clinical Trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2017
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 12, 2017
CompletedFirst Posted
Study publicly available on registry
July 21, 2017
CompletedStudy Start
First participant enrolled
December 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2018
CompletedNovember 7, 2017
November 1, 2017
9 months
July 12, 2017
November 5, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Pink Esthetic Score
photographs
5 months
Secondary Outcomes (7)
facial gingival thickness
5 months
mid-buccal gingival level
5 months
interproximal gingival level
5 months
- width of keratinized gingiva (KG
5 months
Crestal bone loss
5 months
- +2 more secondary outcomes
Study Arms (2)
PRF with immediate implants
EXPERIMENTALImmediate implants placed and covered with two prf layers
palatal pedicle graft
ACTIVE COMPARATORimmediate implant placement followed by soft tissue augmentation by oalatal pedicle graft
Interventions
Eligibility Criteria
You may qualify if:
- Absence of periodontal disease or a periapical infection
- Adequate native bone to achieve implant primary stability
- The need for a single-tooth replacement in the anterior maxilla (from the second bicuspid to the second bicuspid), subsequent to an inevitable tooth extraction.
You may not qualify if:
- Systemic conditions/disease that contraindicated surgery
- Radiation therapy in the head and neck region or chemotherapy during the 12 months prior to surgery.
- Patients who have any habits that might jeopardize the osseointegration process, such as current smokers.
- Patients with parafunctional habits that produce overload on implant, such as bruxism and clenching.
- Patients who have inadequate interarch space for the prosthetic part.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
July 12, 2017
First Posted
July 21, 2017
Study Start
December 1, 2017
Primary Completion
September 1, 2018
Study Completion
October 1, 2018
Last Updated
November 7, 2017
Record last verified: 2017-11